about
In vitro selection of modified RNA aptamers against CD44 cancer stem cell markerFunctionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.Selection and targeting of EpCAM protein by ssDNA aptamer.Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model.Gold-coated plant virus as computed tomography imaging contrast agentAptamer-guided nanomedicines for anticancer drug deliveryDownregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to DoxorubicinAssociation of Breastfeeding Duration with Susceptibility to Allergy, Influenza, and Methylation Status of TLR1 Gene
P50
Q35028671-1A574980-72BD-479C-92F4-81D3A52350CEQ38303383-E499F5DA-DE50-4B28-8A4C-A4B3DE3277B2Q47134382-1178FFC2-0F92-498B-8DE8-5A6B0156AE1DQ49578369-2AB9CAD1-EE31-4EDD-9921-B8AA94EF537AQ91015555-AE1C1793-6D85-45E5-A42D-91ED34EA4963Q91867413-991A155D-C6E4-4FB1-A3C5-A3AEBE3F7DA8Q92258672-29D7CE7A-E1A6-44C4-90A6-4F12368FF617Q92906353-8155E625-CD69-4CDF-8217-BF03D23C2742
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Walhan Alshaer
@en
Walhan Alshaer
@nl
type
label
Walhan Alshaer
@en
Walhan Alshaer
@nl
prefLabel
Walhan Alshaer
@en
Walhan Alshaer
@nl
P31
P496
0000-0003-2946-7328